Numerous experimental findings in animals as well as epidemiological and clinical observations support the hypothesis that certain viruses play a role in the pathogenesis of Type 1 (insulin-dependent) diabetes mellitus [1, 3] . Directly or via immune and/or autoimmune processes viruses might induce B-cell damage. Among the proposed diabetogenic viral agents, the most likely candidates are the mumps and the Coxsackie viruses. Virus replication has been detected in cultured human B cells by the double-labelled antibody technique for mumps and Coxsackie viruses [4, 10] . Numerous publications have proven that there is a relationship between the length of time since mumps infection and the occurrence of Type I diabetes mellitus [5] . According to these observations, which are usually of an anecdotal case report nature, the interval between the two illnesses ranges from a few days to several months. They all involve case studies and individual observations within families whose members developed Type 1 diabetes mellitus. It is admittedly impossible to conclude without doubt from such case report observations that there is some causal relationship between the two illnesses.
Helmke et al. [2] recently studied islet cell antibodies (ICA) and islet cell surface antibodies (ICSA) in 127 non-diabetic children after mumps infection. The study group consisted of selected mumps patients characterized by complications of previous mumps infection (meningoencephalitis, pancreatitis). At the same time, we investigated prospectively the possible relationship of glucose tolerance, B-cell function, diabetes-associated HLA antigens, haptoglobin phenotype, ICA and ICSA in 125 randomly selected non-diabetic subjects with antecedent mumps infection with and without complications [7] . According to the study of Helmke et al. [2] , all but one of the patients studied had normal glucose tolerance over the subsequent 3 to 5 years. In our study, impaired glucose tolerance was diagnosed in 3.2% (n= 3), but onset of diabetes mellitus did not appear within 14 to 26 months after mumps infection. The proportion of complications (e. g. pancreatitis, meningitis, orchitis) during antecedent mumps infection was higher in patients older than 16 years of age than in children. No relationships, however, existed between complications of antecedent mumps and the subsequent result of the glucose tolerance test.
Helmke et al. [2] found ICSA in 42 out of 68 sera from children (62%) with mumps infection. According to our study, ICSA were detectable in about 36% of children and 62% in patients older than 16years of age. ICSA persisted in more than 50% of subjects up to 26 months after mumps infection [7] . According to the study of Helmke et al. [2] , the sera tested for ICSA were absorbed with rat liver cells as well as spleen cells. In contrast, no pre-absorption experiments were carried out in our laboratory. Therefore, non-organ specific antibodies cross-reacting with surface components of rat islet cells may also be expected in the heterogenous pool of ICSA. According to this method, we found a prevalance of ICSA of about 5% in healthy control subjects [9] .
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We investigated further whether ICSA of non-diabetic subjects with an antecedent mumps infection exhibit complement-dependent cytotoxicity against rat islets of Langerhans in vitro [8] . Out of a total of 24subjects, the sera of 11 exhibited cytotoxicity. Ten out of the 11 subjects with cytotoxic sera had HLA DR3 and/or DR4, whereas DR3 was present in 3 out of 13 subjects with non-cytotoxic sera. There was no relationship between B-cell function in vivo and the capability of patient sera to damage islet cells in vitro. The results support the hypothesis that complement-dependent cytotoxicity of ICSA may be involved in the B-cell damage in some subjects with an antecedent mumps infection and diabetic risk. In the study of Helmke et ai. [2] , HLA-typing was carried out in 45 mumps-infected children. The typical HLA-associations as established for Type 1 diabetes were not seen in lCA-positive mumps patients. In agreement with the authors, we failed to establish any relationship between the most common diabetes-associated HLA markers and the occurrence of both ICA and ICSA in 125 randomly selected subjects with antecedent mumps infection [7] . In addition, there was no relationship between ICA or ICSA and B-cell function (fasting C-peptide and insulin response to OGTT) and haptoglobin phenotype in the study group. We have concluded from our study that the results do not support a close temporal relationship between mumps infection and onset of Type 1 diabetes mellitus. The view is in agreement with our findings of a screening programme for diabetes in 1080 unselected children from rural and urban communities who had had mumps 10-19 months previously [6] . 1069 (99%) of the 1080 subjects had no diabetes mellitus, diabetic symptoms or glucosuria. A positive urine screen was obtained in 11 subjects (1%) studied; all these cases finally had normal glucose tolerance tests. The prevalence of Type 1 diabetes mellitus in children (<16 years of age) in the year of the study was 42.9 per 100000 subjects of the general national population. On the other hand, the prevalence of mumps infection in the general population at the ages studied was 5012.7 per 100000 [6] . Thus, purely on a statistical basis, one would have expected a higher number of Type 1 diabetes cases if mumps were closely related to diabetes.
In conclusion, the pathogenetic role of mumps virus and islet cell antibodies an their possible relation to slow progressive B-cell destruction is still to be ascertained. We agree with Helmke et al. [2] that a virus infection could be the final insult to the immune system or islets which are undergoing destructive autoimmune processes leading to the onset of clinical diabetes. It seems likely that, if mumps infection has a diabetogenic role, it is only relevant to a few cases.
Yours sincerely, K. P. Ratzmann
Nontraumatic rhabdomyolysis during diabetic ketoacidosis
Dear Sir,
In a recent article, Moller-Petersen et al. [1] evaluated the frequency of nontraumatic rhabdomyolysis in diabetic ketoacidosis. They concluded that "the pathogenic mechanism leading to rhabdomyolysis in diabetic ketoacidosis remains unsettled". In a young patient recently admitted for ketoacidosis and presenting rhabdomyolysis, we also looked for unusual causes of rhabdomyolysis (Table 1) .
This 20-year-old female was previously in good health, and never presented cramp nor muscle pain. During two months she experienced fatigue and progressive weight loss; four days before entry into hospital, she complained of dyspnea, polyuria and vomiting. On admission, the diagnosis of ketoacidosis, clinically evident, was confirmed by glycosuria, ketonuria, hyperglycaemia (52 mmol/l), low plasma standard bicarbonate concentration (4.8 mmol/1) and arterial pH(7.03). Serum urea and creatinine were elevated (16.8 and 0.43 mmol/1 respectively) and creafine kinase activity in serum was moderately increased to 120 U/1 (N: 5-130). Serum phosphorus was normal (1.29 mrnol/1). Treatment was immediately started with classical rehydration by intravenous saline containing sodium bicarbonate and potassium chloride combined with low-dose insulin given intravenously by a syringe pump. Glucose infusion was progressively introduced when glycaemia decreased. Clinical and biological improvement was rapidly obtained (Table 1) . Surprisingly, serum creatine kinase activity increased dramatically to 7690 U/1 on the next day after admission, then progressively decreased to normal values within 15 days. Usual causes of rhabdomyolysis [2] were rapidly excluded (no muscular trauma or compression, no intramuscular injection, normal electrocardiograms...).
We suggest the hypothesis of a metabolic disease such as Mc Ardle disease, phosphofructokinase deficiency or other glycolytic defect, possibly revealed by ketoacidosis, and responsible for rhabdomyolysis in this case. To screen for disorders of anaerobic glycolysis, we used the procedure proposed by Layzer [3] . In fact, two weeks after ketoacidosis, all the tests proved normal: ischaemic exercise with sphygmomanometer cuff placed around the upper arm was possible during more than one minute, ischaemic exercise with ergometric bicycle produced a normal rise in blood lactate levels (from 1.30 to 7.10retool/I). Finally, muscle biopsy only demonstrated rnyolysis sequelae but did not find histoenzymologic abnormalities (particularly for phosphorylase activity).
In conclusion, we wish to emphasize that, in our opinion, enzymatic defects of glycolysis are probably not the cause of rhabdomyolysis during diabetic ketoacidosis. Moreover, in our observation, as in Moller-Petersen's case, it is noteworthy that maximal rhabdomyolysis occured a few hours after beginning treatment. Rhabdomyolysis might there fore be related to rehydration and/or correction of hyperglycaemia and ketoacidosis. In this setting, the fall in serum phos-
